Mckesson Medical-Surgical Inc. Corporate Office recalls PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use
See all recalls from Mckesson Medical-Surgical Inc. Corporate Office →Recalled Product
PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21
Hazard / Issue
CGMP Deviations; potential temperature excursions due to transit delays
Issued by
FDA
Affected States: OH, VA, FL
Lot/Code Info: Lot: 1180924, Expiration date: 6/30/2027.
✅ What Should You Do?
- 1Stop taking this medication and contact your doctor or pharmacist immediately.
- 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
- 3Check the lot number on your bottle or packaging against the recalled lots listed above.
- 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
Looking for a safe alternative?
Search Amazon for PROLIA (denosumab), injection, 60mg/mL, →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime